MSV
MN Services Vermogensbeheer Portfolio holdings
AUM
$14.4B
This Quarter Return
-2.89%
1 Year Return
+23.85%
3 Year Return
+98.85%
5 Year Return
–
10 Year Return
–
AUM
$10.4B
AUM Growth
-$349M
(-3.3%)
Cap. Flow
+$53M
Cap. Flow
% of AUM
0.51%
Top 10 Holdings %
Top 10 Hldgs %
16.66%
Holding
456
New
1
Increased
216
Reduced
4
Closed
11
Top Buys
| 1 |
NVIDIA
NVDA
|
$3.39M |
| 2 |
Tesla
TSLA
|
$3.1M |
| 3 |
UnitedHealth
UNH
|
$2.77M |
| 4 |
Visa
V
|
$2.69M |
| 5 |
Eli Lilly
LLY
|
$2.69M |
Top Sells
| 1 |
ConocoPhillips
COP
|
$25M |
| 2 |
Schlumberger
SLB
|
$13.7M |
| 3 |
EOG Resources
EOG
|
$13.2M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
$9.49M |
| 5 |
Johnson & Johnson
JNJ
|
$9.17M |
Sector Composition
| 1 | Technology | 26.14% |
| 2 | Healthcare | 20.18% |
| 3 | Financials | 12.23% |
| 4 | Industrials | 10.47% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Deere & Co
DE
$127B
| $51.8M | 0.5% |
137,300
+2,400
| +2% | +$906K |
|
52
Starbucks
SBUX
$99.2B
| $51.2M | 0.49% |
561,100
+9,600
| +2% | +$876K |
|
53
Medtronic
MDT
$118B
| $50.8M | 0.49% |
648,900
+10,500
| +2% | +$823K |
|
54
Elevance Health
ELV
$72.4B
| $50.4M | 0.49% |
115,800
+2,100
| +2% | +$914K |
|
55
TJX Companies
TJX
$155B
| $50.1M | 0.48% |
563,152
+14,100
| +3% | +$1.25M |
|
56
Intuitive Surgical
ISRG
$158B
| $50M | 0.48% |
171,100
+3,100
| +2% | +$906K |
|
57
Automatic Data Processing
ADP
$121B
| $48.6M | 0.47% |
202,165
+3,400
| +2% | +$818K |
|
58
Walmart
WMT
$793B
| $48.3M | 0.47% |
906,300
+22,800
| +3% | +$1.22M |
|
59
Blackrock
BLK
$170B
| $47.3M | 0.46% |
73,186
+1,300
| +2% | +$840K |
|
60
Mondelez International
MDLZ
$79.3B
| $46.2M | 0.45% |
666,400
+12,000
| +2% | +$833K |
|
61
American Express
AXP
$225B
| $46.1M | 0.44% |
309,012
+5,600
| +2% | +$835K |
|
62
Marsh & McLennan
MMC
$101B
| $46.1M | 0.44% |
242,088
+4,500
| +2% | +$856K |
|
63
Gilead Sciences
GILD
$140B
| $45.8M | 0.44% |
610,555
+10,900
| +2% | +$817K |
|
64
Stryker
SYK
$149B
| $45.6M | 0.44% |
166,800
+3,100
| +2% | +$847K |
|
65
Vertex Pharmaceuticals
VRTX
$102B
| $43.8M | 0.42% |
125,900
+3,200
| +3% | +$1.11M |
|
66
Analog Devices
ADI
$120B
| $43.3M | 0.42% |
247,293
+4,400
| +2% | +$770K |
|
67
Regeneron Pharmaceuticals
REGN
$59.8B
| $43.2M | 0.42% |
52,500
+1,300
| +3% | +$1.07M |
|
68
Chubb
CB
$111B
| $42.2M | 0.41% |
202,670
+3,700
| +2% | +$770K |
|
69
Eaton
ETN
$134B
| $41.5M | 0.4% |
194,714
+3,500
| +2% | +$746K |
|
70
Lam Research
LRCX
$124B
| $41.4M | 0.4% |
659,840
+17,000
| +3% | +$1.07M |
|
71
Charles Schwab
SCHW
$175B
| $40.4M | 0.39% |
735,200
+13,900
| +2% | +$763K |
|
72
Progressive
PGR
$145B
| $39.9M | 0.38% |
286,573
+5,300
| +2% | +$738K |
|
73
Zoetis
ZTS
$67.6B
| $39.4M | 0.38% |
226,503
+4,300
| +2% | +$748K |
|
74
Boston Scientific
BSX
$159B
| $37.2M | 0.36% |
704,000
+13,400
| +2% | +$708K |
|
75
Becton Dickinson
BDX
$54.3B
| $35.9M | 0.35% |
139,004
+3,700
| +3% | +$957K |
|